We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information to support your recovery after COVID-19.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
What to do if you think you are a victim of identity theft or fraud, and what signs to look out for.
The MHRA was alerted by Beyond Compliance and the UK National Joint Registry (NJR) to a significantly higher revision rate observed with the ORIGIN PS patient-matched total knee replacement.
Check the tariff classification for peptide nisin standardised with sodium chloride
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
SAPIENT enables interoperability of artificial intelligence (AI) enabled sensors, combined with intelligent fusion and sensor management.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Apply to get an EORI number to move goods between Great Britain, Northern Ireland or the Isle of Man, and other countries.
Fresenius Kabi Limited has informed the MHRA of an error on the infusion bag packaged into the specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex.
Make sure that domains that do not send email cannot be used for spoofing.
Use a separate statement of objection form for each Japanese GI product name you object to.
Guidance and resources to resolve common fingermark visualisation queries and help forensic laboratories achieve and maintain ISO 17025.
Product Recall for Vincenza Jewellery Pave Zircon Initial Cord Bracelet presenting a serious chemical risk.
This research project aims to develop improved methods for the determination of mycotoxins.
This document contains the decision made by the Certification Officer in this case.
Information and guidance for verifying your identity.
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.